Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2-Expressing Breast Cancer
Clinical trial NCT03366428 · COMPLETED
Trial details
- NCT number
- NCT03366428
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-26
- Primary completion
- 2018-12-05
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.